NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Short Interest Update

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the target of a large growth in short interest in February. As of February 15th, there was short interest totalling 3,800 shares, a growth of 216.7% from the January 31st total of 1,200 shares. Based on an average daily volume of 65,000 shares, the days-to-cover ratio is currently 0.1 days.

NLS Pharmaceutics Stock Performance

NLSPW traded down $0.00 on Friday, reaching $0.01. 33,416 shares of the company traded hands, compared to its average volume of 72,416. The stock’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.01. NLS Pharmaceutics has a 52-week low of $0.01 and a 52-week high of $0.10.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).